Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$89,088
in 5 filings, $89K under 10b5-1 plans

Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-08-11 Flagship Ventures Fund IV, L.P. 10% owner Other disposition −1,200,000 2,764,256
2016-08-11 Flagship Ventures Fund IV, L.P. 10% owner Other disposition −300,000 691,060
2016-08-11 Flagship Ventures Fund IV, L.P. 10% owner Other disposition −50,271 0
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion +2,039,549 2,039,549
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion +1,617,015 3,656,564
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion +307,692 3,964,256
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion +509,885 509,885
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion +404,253 914,138
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion +76,922 991,060
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion · Series A-1 Preferred Stock −5,302,834 0
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion · Series A-2 Preferred Stock −4,204,240 0
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion · Series B Preferred Stock −800,001 0
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion · Series A-1 Preferred Stock −1,325,708 0
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion · Series A-2 Preferred Stock −1,051,060 0
2016-02-08 Flagship Ventures Fund IV, L.P. 10% owner Conversion · Series B Preferred Stock −199,999 0

Page 1 of 1 · 15 trades